COMMUNIQUÉS West-GlobeNewswire

ReWalk Robotics to Present at Upcoming Healthcare Conferences
06/03/2018
YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., March 06, 2018 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK ) (“ReWalk” or “the Company”) today announced that Larry Jasinski, Chief Executive Officer, will present [...]
Switching clocks can wreak havoc on our sleep patterns
06/03/2018
CALGARY, Alberta, March 06, 2018 (GLOBE NEWSWIRE) -- Charles H. Samuels MD, CCFP, DABSM President, Canadian Sleep Society, Medical Director, Centre for Sleep and Human Performance Daylight Savings Time begins this [...]
Reprocessed VNUS ClosureFast Catheters – 6 Years of Superior Performance
06/03/2018
WATERBURY, Conn., March 06, 2018 (GLOBE NEWSWIRE) -- Northeast Scientific Inc. (NES) has released 5-year results proving that the use of their reprocessed medical devices is safe, effective and smart. NES has [...]
Aeglea BioTherapeutics to Present Adult Repeat Dose Data at 2018 Annual Meeting of The Society for Inherited Metabolic Disorders
06/03/2018
AUSTIN, Texas, March 06, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE ), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with [...]
Globus Medical Enters Trauma Market
06/03/2018
AUDUBON, Pa., March 06, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED ), a leading musculoskeletal solutions company, is pleased to announce its entry into the orthopedic trauma market. Globus Medical has [...]
Supernus to Present at the 2018 Cowen Health Care Conference
06/03/2018
ROCKVILLE, Md., March 06, 2018 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN ), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central [...]
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
06/03/2018
WAYNE, Pa., March 06, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS ), a dermatologist-led, biopharmaceutical company focused on identifying, developing and commercializing innovative and [...]
TRACON Pharmaceuticals to Present at 30th Annual ROTH Conference
06/03/2018
SAN DIEGO, March 06, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON ), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer [...]
Zafgen Reports Fourth Quarter and Full Year 2017 Financial Results; Announces Positive Interim Data from Ongoing ZGN-1061 Phase 2 Proof-of-Concept Trial in Patients with Type 2 Diabetes
06/03/2018
ZGN-1061 interim data suggest compound is safe and well-tolerated; no safety signals and placebo-like side effect profile ZGN-1061 interim efficacy data indicate significant A1C lowering vs. placebo at 8 weeks ZGN-1258 [...]
Portola Pharmaceuticals to Present at Two Upcoming Investor Conferences
06/03/2018
SOUTH SAN FRANCISCO, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (NASDAQ: PTLA ) today announced that Bill Lis, chief executive officer, will present at the following conferences in March [...]
Atara Biotherapeutics to Present at the Cowen and Company 38th Annual Health Care Conference
06/03/2018
SOUTH SAN FRANCISCO, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA ), a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients with cancer, [...]
National Coordination Center to Support VA EMR with Resources from Top U.S. Health Care Organizations
06/03/2018
WASHINGTON, March 06, 2018 (GLOBE NEWSWIRE) -- The founding members of the National Coordination Center's Department of Veterans Affairs (VA) Steering Committee today announced their commitment to help support the VA’s [...]
Clearside Announces Proposed Public Offering of Common Stock
06/03/2018
ALPHARETTA, Ga., March 06, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ: CLSD ), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases [...]
Editas Medicine Announces Fourth Quarter and Full Year 2017 Results and Update
06/03/2018
EDIT-101 for Leber Congenital Amaurosis type 10 (LCA10) on track for mid-2018 Investigational New Drug (IND) filing Expecting at least five clinical-stage programs by end of 2022 as part of EM22 five-year goals Year-end [...]
Nuvectra™ Reports Fourth Quarter and Full Year 2017 Financial Results
06/03/2018
PLANO, Texas, March 06, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR ), a neurostimulation medical device company, today announced financial results for the fourth quarter and full year ended December 31 [...]
Optinose to Report Fourth Quarter and Full Year 2017 Financial Results and Corporate Updates on March 13, 2018
06/03/2018
YARDLEY, Pa., March 06, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ: OPTN ), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the Company will [...]
Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Financial Results
06/03/2018
ZX008 Granted Breakthrough Therapy Designation in Dravet syndrome by FDA Last patient randomized into second Phase 3 clinical trial of ZX008 in patients with Dravet syndrome, Study 1504 Initiated global Phase 3 clinical [...]
Adverum Biotechnologies Reports Fourth Quarter 2017 Financial Results and Provides Corporate Update
06/03/2018
MENLO PARK, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM ), a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, today [...]
Align Technology to Host Investor Day on May 23, 2018
06/03/2018
SAN JOSE, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN ) today announced that it will host an Investor Day on Wednesday, May 23, 2018, at the Park Central Hotel in New York City. [...]

Pages